Yang Yufan, Xiao Zhenghui, Huang Jiaotian, Gong Ling, Lu Xiulan
Department of Intensive Care Unit of Hunan Children's Hospital, Changsha, China.
Front Pediatr. 2022 Jan 21;9:791781. doi: 10.3389/fped.2021.791781. eCollection 2021.
The benefits of extracorporeal membrane oxygenation in patients with refractory septic shock remain controversial. Current guidelines on the management of refractory septic shock recommend the consideration of extracorporeal membrane oxygenation as a salvage therapy. The difference between adults and children with septic refractory shock treated with extracorporeal membrane oxygenation has not been previously analyzed. We aimed to review peer-reviewed publications on the role of extracorporeal membrane oxygenation in adults and children with refractory septic shock.
Studies reporting on mortality in both adults and children with refractory septic shock supported with extracorporeal membrane oxygenation published in PubMed, Cochrane Library, and Embase databases were included in the meta-analysis. Study eligibility was independently assessed by two authors, and disagreements were resolved by a third author. The outcome measure was survival at discharge. Subgroup analysis included the adult and pediatric groups.
Of the 293 articles screened, 14 original articles were identified for systematic review and meta-analysis. The cumulative estimate of survival (14 studies, 535 patients) in the cohort was 39% (95% confidence interval [CI]: 27-51%). During the subgroup analysis, the cumulative estimate of survival at discharge in the adult group (6 studies, 276 patients) in the cohort was 18% (95% CI: 10-27%), and that in the pediatric group (8 studies, 259 patients) was 53% (95% CI: 47-59%).
The survival rate of adults with refractory septic shock requiring extracorporeal membrane oxygenation was 18%, and children with refractory septic shock requiring extracorporeal membrane oxygenation had a higher survival rate (53%) than adults.
体外膜肺氧合在难治性感染性休克患者中的益处仍存在争议。当前关于难治性感染性休克管理的指南建议考虑将体外膜肺氧合作为一种挽救治疗方法。此前尚未分析接受体外膜肺氧合治疗的感染性难治性休克成人与儿童之间的差异。我们旨在综述关于体外膜肺氧合在成人和儿童难治性感染性休克中作用的同行评审出版物。
纳入在PubMed、Cochrane图书馆和Embase数据库中发表的关于接受体外膜肺氧合支持的难治性感染性休克成人和儿童死亡率的研究,进行荟萃分析。两名作者独立评估研究的纳入资格,分歧由第三位作者解决。结局指标为出院时的生存率。亚组分析包括成人组和儿童组。
在筛选的293篇文章中,确定了14篇原始文章进行系统评价和荟萃分析。该队列中的累积生存估计值(14项研究,535例患者)为39%(95%置信区间[CI]:27 - 51%)。在亚组分析中,该队列中成人组(6项研究,276例患者)出院时的累积生存估计值为18%(95%CI:10 - 27%),儿童组(8项研究,259例患者)为53%(95%CI:47 - 59%)。
需要体外膜肺氧合的难治性感染性休克成人的生存率为18%,需要体外膜肺氧合的难治性感染性休克儿童的生存率(53%)高于成人。